Koiwai O, Aono S, Adachi Y, Kamisako T, Yasui Y, Nishizawa M, Sato H
Laboratory of Biochemistry, Aichi Cancer Center Research Institute, Nagoya, Japan.
Hum Mol Genet. 1996 May;5(5):645-7. doi: 10.1093/hmg/5.5.645.
Crigler-Najjar syndrome type II (CN-II) is caused by a severely reduced hepatic activity of bilirubin UDP-glucuronosyltransferase (UGT). Recently, by the analysis of the genetic background of CN-II patients, it has been clarified that the patients carry homozygous missense mutations or nonsense plus missense mutations on the gene for UGT, and CN-II was inherited as an autosomal recessive trait. We encountered a new case which had a nonsense mutation caused by a single nucleotide substitution on one allele. This indicates that CN-II is also inherited as a dominant trait as well as a recessive trait. Expression study in vitro strongly suggests that the disease in this case is caused by a dominant negative mutation by forming a heterologous subunit structure.
II型克里格勒-纳贾尔综合征(CN-II)是由胆红素UDP-葡萄糖醛酸基转移酶(UGT)的肝脏活性严重降低引起的。最近,通过对CN-II患者的基因背景分析,已明确患者在UGT基因上携带纯合错义突变或无义加错义突变,且CN-II以常染色体隐性性状遗传。我们遇到了一个新病例,该病例在一个等位基因上因单核苷酸替换而产生了无义突变。这表明CN-II也可作为显性性状以及隐性性状遗传。体外表达研究强烈提示,该病例中的疾病是通过形成异源亚基结构由显性负性突变引起的。